VHL and neoplasm: As a third example, DeepMVP predicted that p.L169P in the tumor-suppressor VHL, recurrent in clear cell renal carcinoma but with unclear functional consequences47, would increase phosphorylation at S168 (delta score, 0.98; Fig. 6e).